Literature DB >> 21084499

Two isoforms of the protein kinase pUL97 of human cytomegalovirus are differentially regulated in their nuclear translocation.

Rike Webel1, Jens Milbradt, Sabrina Auerochs, Vera Schregel, Christian Held, Katharina Nöbauer, Ebrahim Razzazi-Fazeli, Christophe Jardin, Thomas Wittenberg, Heinrich Sticht, Manfred Marschall.   

Abstract

The pUL97 protein kinase encoded by human cytomegalovirus is a multifunctional determinant of the efficiency of viral replication and phosphorylates viral as well as cellular substrate proteins. Here, we report that pUL97 is expressed in two isoforms with molecular masses of approximately 90 and 100 kDa. ORF UL97 comprises an unusual coding strategy in that five in-frame ATG start codons are contained within the N-terminal 157 aa. Site-directed mutagenesis, transient expression of point and deletion mutants and proteomic analyses accumulated evidence that the formation of the large and small isoforms result from alternative initiation of translation, with the start points being at amino acids 1 and 74, respectively. In vitro kinase assays demonstrated that catalytic activity, in terms of autophosphorylation and histone substrate phosphorylation, was indistinguishable for the two isoforms. An analysis of the intracellular distribution of pUL97 by confocal laser-scanning microscopy demonstrated that both isoforms have a pronounced nuclear localization. Surprisingly, mapping experiments performed to identify the nuclear localization signal (NLS) of pUL97 strongly suggest that the mechanism of nuclear transport is distinct for the two isoforms. While the extreme N terminus (large isoform) comprises a highly efficient, bipartite NLS (amino acids 6-35), a second sequence apparently conferring a less efficient mode of nuclear translocation was identified downstream of amino acid 74 (small and large isoforms). Taken together, the findings argue for a complex mechanism of nuclear translocation for pUL97 which might be linked with fine-regulatory differences between the two isoforms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084499     DOI: 10.1099/vir.0.026799-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.

Authors:  Chou-Wei Chang; Chung-Pei Lee; Yu-Hao Huang; Pei-Wen Yang; Jiin-Tarng Wang; Mei-Ru Chen
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.

Authors:  Rachel B Gill; Scott H James; Mark N Prichard
Journal:  J Gen Virol       Date:  2012-05-02       Impact factor: 3.891

3.  A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.

Authors:  Corina Hutterer; Jan Eickhoff; Jens Milbradt; Klaus Korn; Isabel Zeitträger; Hanife Bahsi; Sabrina Wagner; Gunther Zischinsky; Alexander Wolf; Carsten Degenhart; Anke Unger; Matthias Baumann; Bert Klebl; Manfred Marschall
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

4.  Complex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication.

Authors:  Katie Caviness; Louis Cicchini; Michael Rak; Mahadevaiah Umashankar; Felicia Goodrum
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

5.  Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97.

Authors:  Mirjam Steingruber; Lena Keller; Eileen Socher; Sabrina Ferre; Anne-Marie Hesse; Yohann Couté; Friedrich Hahn; Nicole Büscher; Bodo Plachter; Heinrich Sticht; Manfred Marschall
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

6.  Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.

Authors:  Rike Webel; Morgan Hakki; Mark N Prichard; William D Rawlinson; Manfred Marschall; Sunwen Chou
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

7.  Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.

Authors:  Tarin M Bigley; Justin M Reitsma; Shama P Mirza; Scott S Terhune
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain.

Authors:  Mirjam Steingruber; Eileen Socher; Corina Hutterer; Rike Webel; Tim Bergbrede; Tihana Lenac; Heinrich Sticht; Manfred Marschall
Journal:  Viruses       Date:  2015-08-11       Impact factor: 5.048

9.  The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins.

Authors:  Laura Graf; Rike Webel; Sabrina Wagner; Stuart T Hamilton; William D Rawlinson; Heinrich Sticht; Manfred Marschall
Journal:  Viruses       Date:  2013-12-18       Impact factor: 5.048

10.  Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus.

Authors:  Ren Qi; Zeng Hua-Song; Zeng Xiao-Feng
Journal:  Eur J Med Res       Date:  2013-02-01       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.